Fecal microbiota transplantation in an older patient with Clostridioides difficile recurrent infection. Report of one case

被引:0
|
作者
Nunez, Paulina [1 ,2 ,3 ,4 ]
Quera, Rodrigo [1 ,2 ,3 ]
Von Muhlenbrock, Christian [1 ,2 ,3 ]
Concha, Alexandra [2 ]
Flores, Katherine [2 ]
机构
[1] Univ Andes, Programa Enfermedad Inflamatoria Intestinal, Ctr Enfermedades Digest, Santiago, Chile
[2] Clin Univ Andes, Ctr Endoscopia, Santiago, Chile
[3] Univ Andes, Dept Med Interna, Santiago, Chile
[4] Univ Chile, Hosp San Juan De Dios, Fac Med Occidente, Dept Med Interna, Santiago, Chile
关键词
Aged; Clostridioides difficile; Fecal Microbiota Transplantation; Fidaxomicin; Recurrence;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clostridioides difficile infection (CDI) is a major public health problem and responsible for significant morbidity and mortality. Eighty percent of CDIs occur in adults older than 65 years of age due to a decreased gastrointestinal microbial diversity, immunosenescence and frailty. Thus, the most reported risk factor for recurrent CDI is older age since nearly 60% of cases occur in individuals aged > 65 years. Fecal microbiota transplantation (FMT) is a highly cost-effective alternative to antibiotic treatment for patients with recurrent CDI. We report a 75-year-old male with recurrent CDI, who received a FMT after several unsuccessful antimicrobial treatments. He had a satisfactory evolution after the procedure and remained without diarrhea during the ensuing five months.
引用
收藏
页码:1396 / 1400
页数:5
相关论文
共 50 条
  • [41] Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with Clostridioides difficile Infection
    Yoon, Hyuk
    Shim, Hyun Ik
    Seol, Mijin
    Shin, Cheol Min
    Park, Young Soo
    Kim, Nayoung
    Lee, Dong Ho
    GUT AND LIVER, 2021, 15 (01) : 61 - 69
  • [42] Fecal microbiota transplantation: the need for effective treatment of Clostridioides difficile infection in Pakistan
    Khurram, Subata
    Asad, Ayesha
    Fatima, Syeda Zainab
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2023, 17 (11): : 1626 - 1627
  • [43] The evaluation of fecal microbiota transplantation vs vancomycin in a Clostridioides difficile infection model
    Qiaomai Xu
    Shumeng Zhang
    Jiazheng Quan
    Zhengjie Wu
    Silan Gu
    Yunbo Chen
    Beiwen Zheng
    Longxian Lv
    Lanjuan Li
    Applied Microbiology and Biotechnology, 2022, 106 : 6689 - 6700
  • [44] Practical clues for a fecal microbiota transplantation by colonoscopy for recurrent Clostridium difficile infection. Experience in a University center
    Cruz, Ricardo
    Monrroy, Hugo
    Flandez, Jorge
    Perez, Carlos M.
    Alvarez-Lobos, Manuel
    Hernandez-Rocha, Cristian
    REVISTA CHILENA DE INFECTOLOGIA, 2018, 35 (05): : 566 - 573
  • [45] Outcomes After Fecal Microbiota Transplantation in Combination With Bezlotoxumab for Inflammatory Bowel Disease and Recurrent Clostridioides difficile Infection
    Allegretti, Jessica R.
    Axelrad, Jordan
    Dalal, Rahul S.
    Kelly, Colleen R.
    Grinspan, Ari
    Fischer, Monika
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (07) : 1433 - 1436
  • [46] Cost-effectiveness analysis of sequential fecal microbiota transplantation for fulminant Clostridioides difficile infection
    Gupta, Sanchit
    Zhu, Jinyi
    McCarty, Thomas R.
    Pruce, Jordan
    Kassam, Zain
    Kelly, Colleen
    Fischer, Monika
    Allegretti, Jessica R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (09) : 2432 - 2440
  • [47] Fecal microbiota transplantation and Clostridioides difficile infection among privately insured patients in the United States
    El Halabi, Jessica
    Palmer, Nathan
    Fox, Kathe
    Kohane, Isaac
    Farhat, Maha R.
    JOURNAL OF GASTROENTEROLOGY, 2022, 57 (01) : 10 - 18
  • [48] Efficacy and safety of commercialized fecal microbiota transplant for the treatment of recurrent Clostridioides difficile infection
    Yendrapalli, Usha
    Edwards, Jonathan
    Belk, Madeline
    Steuber, Taylor
    Hassoun, Ali
    INFECTION DISEASE & HEALTH, 2023, 28 (01) : 71 - 73
  • [49] A Randomized Controlled Trial of Efficacy and Safety of Fecal Microbiota Transplant for Preventing Recurrent Clostridioides difficile Infection
    Drekonja, Dimitri M.
    Shaukat, Aasma
    Huang, Yuan
    Zhang, Jane H.
    Reinink, Andrew R.
    Nugent, Sean
    Dominitz, Jason A.
    Davis-Karim, Anne
    Gerding, Dale N.
    Kyriakides, Tassos C.
    CLINICAL INFECTIOUS DISEASES, 2024, 80 (01) : 52 - 60
  • [50] Fecal microbiota transplantation: a review on current formulations in Clostridioides difficile infection and future outlooks
    Rakotonirina, Adele
    Galperine, Tatiana
    Allemann, Eric
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (07) : 929 - 944